Health Populi

MAY 4, 2023

It’s a volume speaking volumes on the current picture of prescribed meds, spending and revenues, health care utilization trends, and a forecast looking out to 2027. health care: “Wake up, public health!” In my read of this year’s review, I see a flashing light for U.S.

Public Health 156

Public Health Mental health Life Science Telehealth 156

Health Populi

JANUARY 22, 2020

Together, these three factors erode workers’ confidence in jobs and their personal household economies and financial health. The second chart comes from the study, quantifying global citizens’ trust levels by industry sector since 2012.

BioTech 261

BioTech Primary Care Public Health Mental health 261

Health Populi

MARCH 11, 2021

Note: I may be biased as a University of Michigan graduate of both the School of Public Health and Rackham School of Graduate Studies in Economics]. health care, patient assistance programs, Medicare Advantage plans, and the bundling of proven high-value preventive services into the Affordable Care Act.

Health Policy 245

Health Policy Medicare Pharmaceuticals Life Science 245

Health Populi

JUNE 24, 2021

The third chart details some of these points: On the macroeconomic side of the forecast, we see increasing private consumption, higher inflation, less public sector support (e.g., We also expect innovation to come out of pharma and biotech labs, and who will pay for new-new therapies?

BioTech 270

BioTech Pharmaceuticals Public Health Telehealth 270

Health Populi

JANUARY 18, 2019

Increasingly, as patients bear more first-dollar costs through high-deductible health plans, co-payments and co-insurance sharing, the patient-as-payor has become more sensitive to these prices. Chan School of Public Health with POLITICO looked into Americans’ Health and Education Priorities for the New Congress in 2019.

BioTech 160

BioTech Medicare Medical Billing Patient Experience 160

Health Populi

FEBRUARY 22, 2021

The study was written up by Beth Snyder Bulik in FiercePharma. Surprising, because technology [and health] underpin virtually all of the fastest-growing brands in 2020, shown in the second chart from Morning Consult’s study of U.S. Among the top 20 in this study were two pharma brands — Pfizer and AstraZeneca.

Life Science 386

Life Science Pharmaceuticals Public Health BioTech 386